Nicole R Lifson is a Boston, Massachusetts based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Nicole R Lifson is 1014020 for Ophthalmology in Massachusetts. Nicole R Lifson is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Nicole R Lifson speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Female
Practice Address:
243 Charles St, Boston, Massachusetts, 02114-3096
Phone:
617-573-3288
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1730743477
NPI Enumeration Date:
29 Apr, 2019
NPI Last Update On:
05 Jul, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Nicole R Lifson are as mentioned below.
License Number
Specialization
State
Status
1014020
Ophthalmology
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
243 Charles St, Boston, Massachusetts
Zip:
02114-3096
Phone Number:
617-573-3288
Fax Number:
--
Patients can reach Nicole R Lifson at 243 Charles St, Boston, Massachusetts or can call to book an appointment on 617-573-3288. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.